| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |